Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis

Table 2 Adverse events leading to discontinuation of study medication, and their relationship to study medication n (%)

	2-wk group (n = 151)		8 wk group (n = 154)		Total (n = 305)
	Mild	Moderate	Mild	Moderate	Mild	Moderate
Patients with at least one AE	0	1 (0.7)	3 (1.9)	2 (1.3)	3 (1.0)	3 (1.0)
Gastrointestinal disorders	0	0	3 (1.9)	2 (1.3)	3 (1.0)	2 (0.7)
Nausea	0	0	1 (0.6)1	2 (1.3)2	1 (0.3)	2 (0.7)
Abdominal discomfort	0	0	1 (0.6)1	1 (0.6)1	1 (0.3)	1 (0.3)
Constipation	0	0	0	1 (0.6)1	0	1 (0.3)
Frequent bowel movements	0	0	1 (0.6)1	0	1 (0.3)	0
Abdominal pain, upper	0	0	0	1 (0.6)1	0	1 (0.3)
Eye disorders	0	0	1 (0.6)	0	1 (0.3)	0
Vision blurred	0	0	1 (0.6)	0	1 (0.3)	0
Musculoskeletal and connective tissue disorders	0	1 (0.7)	0	0	0	1 (0.3)
Back pain	0	1 (0.7)	0	0	0	1 (0.3)
Renal and urinary disorders	0	1 (0.7)	0	0	0	1 (0.3)
Dysuria	0	1 (0.7)	0	0	0	1 (0.3)
Respiratory, thoracic and mediastinal disorders	0	0	0	1 (0.6)	0	1 (0.3)
Cough	0	0	0	1 (0.6)	0	1 (0.3)

¹Related to study medication;

²One case related to study medication. One patient was counted at most once per category.